PAR-25-343-Full-Announcement.html

This is a Funding Opportunity Announcement (FOA) for a U01 Cooperative Agreement issued by the National Institute on Deafness and Other Communication Disorders (NIDCD) under PAR-25-343. The opportunity supports clinical trials focused on interventions for communication disorders that meet specific criteria: requiring FDA oversight, establishing efficacy, or having higher risk for physical/psychological harm. The agreement involves collaboration between an NIDCD Project Scientist and the investigator.

The funding is available through CFDA 93.173 (Research Related to Deafness and Communication Disorders) and is administered by the Department of Health and Human Services/National Institutes of Health. Eligible applicants include state and local governments, higher education institutions, tribal organizations, housing authorities, for-profit and nonprofit organizations, and small businesses. The focus is specifically on clinical trials that will identify effective treatments or preventive measures for communication disorders, with emphasis on studies requiring additional oversight due to their scope or risk level.